Dr. Julie Trulson is Vice President & Head of CMC at Asher Biotherapeutics. She has 25 years of experience in biopharmaceutical sciences, and has led teams in CMC and Process Development at innovators and CDMOs. Prior to joining Asher Biotherapeutics, she was CMC Team Leader at Allogene Therapeutics, working on CAR-T programs. Before that, she headed CMC at OncoMed Pharmaceuticals. Julie also has experience earlier in her career at Boehringer Ingelheim and Amgen. She received her BS in Biochemistry from Washington State University and her Ph.D. in Chemistry from the University of California at Santa Cruz.